Professor TEH Bin Tean
Singapore Translational Cancer Consortium (STCC)
Deputy Director (Research)
National Cancer Centre Singapore
Deputy Director (Scientific)
SingHealth Duke-NUS Institute of Precision Medicine
Duke-NUS Medical School, Singapore
Professor Teh Bin Tean obtained his MD (1992) from the University of Queensland, Australia and his PhD (1997) from the Karolinska Institute, Sweden.
Following postdoctoral works at Karolinska Institute, Professor Teh joined the Van Andel Research Institute (VARI), USA in 2000 as a Senior Scientific Investigator heading the Laboratory of Cancer Genetics. In 2007, Professor Teh was appointed as the founding Director of the National Cancer Centre Singapore (NCCS)-VARI laboratory, which serves as a bridge between translational research and clinical medicine. In 2010 he received the Singapore Translational Research Investigator Award (STaR) and relocated to Singapore and is currently a full professor in Cancer and Stem Cell Biology (CSCB) Programme at Duke-NUS. He served as the SingHealth Group Director for Translational Research from 2010-2012.
His laboratory focuses on Genomics of Asian-Prevalent Cancers and in the last 5 years have made seminal discoveries in the field including hepatobiliary cancer, herbal carcinogen-related cancer and fibroepithelial tumors of the breast.
He holds Adjunct Professorships at several universities worldwide including Baylor College of Medicine, USA, Nanjing University and Sun Yat-Sen University, China and the Karolinska Institute, Sweden.
Professor Teh has published extensively, with over 400 publications in high impact scientific journals. He is a past and present member of numerous editorial boards for journals including Science Translational Medicine, Lancet Oncology, Cancer Research, Molecular Cancer Therapeutics, International Journal of Cancer. Professor Teh is a recipient of the 2015 Singapore President Science Award and the 2018 AACR (American Association of Cancer Research) Team Science Award.